Mara Sosti/AFP/AFP Argentine police are investigating a deceased Nazi's daughter and son-in-law after a 17th century painting stolen from a Dutch Jewish art collector was recently spotted in a ...
BUENOS AIRES (Reuters) -A federal court in Argentina ordered house arrest for the daughter of a former Nazi official and her husband after a raid failed to locate an iconic painting stolen decades ago ...
Google is strengthening the Gemini app with a significant update that enhances its image editing capabilities. The new Nano Banana model is designed to address earlier shortcomings and provide more ...
GE Aerospace recently announced a joint development program with Axcelis Technologies to advance production-worthy high-voltage silicon carbide superjunction power devices using the Purion XEmax™ high ...
Argentine police continued their hunt Wednesday for a 18th-century Italian portrait believed to have been looted 80 years ago from a Jewish collector by a fugitive Nazi officer who settled in ...
The Tata Institute of Fundamental Research (TIFR) in Hyderabad is poised to acquire groundbreaking ultrashort pulse laser technology by early 2026. This powerful laser, capable of generating 10 to the ...
TSA Has Officially Banned 3 New Items From Checked Bags Kate Middleton and Prince William’s New Home, Forest Lodge, Almost Went to a Different Royal Couple CVS Caremark ordered to pay $290M after ...
Dynatrace is a comprehensive observability platform that goes beyond traditional network monitoring to provide AI-driven insights and visibility. While its premium pricing and complexity may deter ...
Resolution of steatohepatitis with no worsening of liver fibrosis was achieved in 63% of patients taking semaglutide vs 34% taking placebo at week 72. The Food and Drug Administration (FDA) has ...
Data show that the cancer vaccine Cylembio plus Keytruda demonstrated clinical improvement in progression-free survival in unresectable/advanced melanoma. Topline data from a pivotal phase 3 trial ...
Adding the novel CDK4/6 inhibitor tibremciclib (Betta Pharmaceuticals) to second-line fulvestrant significantly extended progression-free survival (PFS) in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results